Obesity trials in China

In China 249 Also abroad 1939

249 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1Not yet taking people in China
A Study of Zovaglutide (ZT002 Injection) in Participants With Hepatic Impairment and Healthy Participants
Where
Chengdu, Chongqing, Zhengzhou
Age
18 years to 75 years
People
24
Run by
Beijing QL Biopharmaceutical Co.,Ltd
See details and how to joinNCT07916194
Phase 2Taking people
UBT251 Injection Phase II Clinical Study (CKD)
Where
Beijing
Age
18 years to 75 years
People
180
Run by
The United Bio-Technology (Hengqin) Co., Ltd.
See details and how to joinNCT07134335
Phase 3Taking people
Safety and Analgesic Efficacy of the Biased μ-Opioid Receptor Agonist Tegileridine for Post-Operative Analgesia in Patients Undergoing Bariatric Surgery
Where
Changchun
Age
18 years to 65 years
People
148
Run by
The First Hospital of Jilin University
See details and how to joinNCT07844512
Phase 3Not yet taking people in China
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Where
Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hefei, Jinan, Luoyang, Luzhou, Nanchang, Nanjing, Nanyang, Ningbo, Qinhuangdao Shi, Shanghai, Shijiazhuang, Suzhou, Xianyang
Age
18 years and over
People
2,115 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07881432 · EU 2026-526047-34-00
Phase 3Not yet taking people in China
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Where
Beijing, Chengdu, Guangzhou, Hangzhou, Harbin, Jinan, Liaoyou, Luoyang Shi, Nanjing, Shanghai, Shijiazhuang, Tianjin, Wenzhou, Xuzhou, Yibin, Zigong
Age
45 years to 64 years
People
3,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00
Phase 1Taking people
Evaluate the Safety and Tolerability of Multiple Doses of JMT206 Injection in Obese Participants
Where
Beijing
Age
18 years to 65 years
People
90
Run by
Shanghai JMT-Bio Inc.
See details and how to joinNCT07840729
No phaseNot yet taking people in China
ERCG vs Intensive Lifestyle Intervention for Weight Regain After GLP-1 RA Discontinuation
Where
Beijing
Age
18 years to 65 years
People
60
Run by
Affiliated Hospital to Academy of Military Medical Sciences
See details and how to joinNCT07908823
No phaseNot yet taking people in China
A Multicenter, Randomized Controlled Superiority Trial Comparing Robotic-Assisted Versus Expert Cognitive Fusion Prostate Biopsy in Obese Men
Where
Shanghai
Age
40 years and over
People
570
Run by
Shanghai East Hospital
See details and how to joinNCT07600216
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Where
Beijing, Cangzhou, Changchun, Changsha, Chengdu, Danyang, Ganzhou, Guiyang, Hengshui, Huizhou, Lanzhou, Panjin, Qiqihar, Shanghai, Suzhou, Xiamen, Xianyang, Zigong
Age
18 years and over
People
2,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00
Phase 3Not yet taking people in China
ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
Where
Chengdu, Luoyang, Nanjing, Shanghai
Age
18 years and over
People
600 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07850063 · EU 2026-527091-88-00
No phaseNot yet taking people in China
Transcutaneous Auricular Vagus Nerve Stimulation Combined With Lifestyle Intervention for Visceral Fat Reduction in Adults With Overweight or Obesity
Where
Zhuhai
Age
18 years to 49 years
People
50
Run by
Guangdong Provincial Hospital of Traditional Chinese Medicine
See details and how to joinNCT07907029
Phase 3Taking people
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Where
Baotou, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chifeng, Chongqing, Daqing, Guangzhou, Haikou, Hangzhou, Harbin, Hefei, Hengyang, Jinan, Kaifeng, Lishui, Luoyang, Nanchang, Nanjing, Pingxiang, Qinhuangdao, Shanghai, Shenyang, Shijiazhuang, Siping, Tai’an, Taiyuan, Tianjin, Wuhan, Wuxi, Xi'an, Xi’an, Yuncheng, Zhengzhou
Age
18 years to 99 years
People
5,056 worldwide
Run by
Amgen
See details and how to joinNCT07037459
No phaseTaking people
Smartwatch-based Intervention for Cardiovascular Health (SWITCH)
Where
Beijing, Cangzhou, Yuhuan
Age
18 years and over
People
1,400
Run by
Beijing Anzhen Hospital
See details and how to joinNCT07372729
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Where
Beijing, Cangzhou, Changchun, Chengdu, Danyang, Ganzhou, Guangzhou, Huizhou, Huzhou, Lanzhou, Nanjing, Panjin, Suzhou, Xianyang
Age
18 years and over
People
1,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784270
No phaseTaking people
Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365')
Where
Shanghai
Age
18 years and over
People
144
Run by
Boston Scientific Corporation
See details and how to joinNCT07195708
No phaseTaking people
OverStitch NXT Endoscopic Suture System
Where
Beijing
Age
18 years and over
People
136
Run by
Boston Scientific Corporation
See details and how to joinNCT07276815
No phaseTaking people
AI-Driven Metabolic Cohort in Overweight/Obese Chinese Adults
Where
Guangzhou
Age
18 years to 60 years
People
2,800
Run by
Zhujiang Hospital
See details and how to joinNCT07584330
No phaseNot yet taking people in China
Mazdutide for Reducing Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients
Where
Beijing
Age
18 years to 75 years
People
700
Run by
Beijing Anzhen Hospital
See details and how to joinNCT07897305
No phaseTaking people
iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) +Optimized Lifestyle Intervention (OLI) vs Sham + OLI for Weight Loss
Where
Beijing
Age
18 years to 65 years
People
216
Run by
Liu Yan
See details and how to joinNCT07237750
No phaseNot yet taking people in China
Individual Variability in Energy Compensation After a 12-Week Supervised Exercise Intervention
Where
Shenzhen
Age
18 years to 40 years
People
150
Run by
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
See details and how to joinNCT07893249
No phaseTaking people
ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management
Where
Chongqing, Fuzhou, Hangzhou, Luzhou, Nanjing, Shanghai, Suzhou, Wenzhou, Wuhan, Xiamen
Age
18 years and over
People
420
Run by
Shanghai Zhongshan Hospital
See details and how to joinNCT07517042
No phaseNot yet taking people in China
Chinese Overweight/Obesity Cohort: Metabolic & Comorbidity Risks
Where
Taiyuan
Age
18 years to 79 years
People
25,974
Run by
Shanxi Bethune Hospital
See details and how to joinNCT07884903
Phase 1Taking people
A Study of IBI3046 in Participants With Overweight or Obesity
Where
Beijing
Age
18 years to 65 years
People
128
Run by
Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT07809945
Phase 1Taking people
A Clinical Trial of TQF3250 Capsules in Overweight/Obese Trial Participants With Poor Weight Control Through Simple Lifestyle Intervention
Where
Beijing, Guangzhou, Hangzhou, Jinan, Luzhou, Shanghai, Wuhan, Xianning, Zhengzhou
Age
18 years to 65 years
People
80
Run by
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07798284
Phase 2Taking people
A Study to Evaluate Efficacy and Safety of BGM0504 Tablets in Overweight or Obese Participants Without Diabetes
Where
Beijing
Age
18 years to 55 years
People
200
Run by
BrightGene Bio-Medical Technology Co., Ltd.
See details and how to joinNCT07658560